Paritaprevir
(1S,4R,6S,7Z,14S,18R)-N-cyclopropylsulfonyl-14-[(5-methylpyrazine-2-carbonyl)amino]-2,15-dioxo-18-phenanthridin-6-yloxy-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide
Molecular Identity
Paritaprevir
(1S,4R,6S,7Z,14S,18R)-N-cyclopropylsulfonyl-14-[(5-methylpyrazine-2-carbonyl)amino]-2,15-dioxo-18-phenanthridin-6-yloxy-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide
PubChem CID: 45110509
2D Structure
Properties
C40H43N7O7S
Molecular Formula
765.90
Molecular Weight
g/mol
765.2945
Exact Mass
Da
4.7
XLogP
Drug-like (Lipinski: < 5)
198
TPSA
May have limited oral absorption
3
H-Bond Donors
10
H-Bond Acceptors
1600
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Paritaprevir1216941-48-8VeruprevirVeruprevir anhydrousABT-450ABT450OU2YM37K86ABT 450(2R,6S,12Z,13aS,14aR,16aS)-N-(Cyclopropylsulfonyl)-6-(5-methylpyrazin-2-carboxamido)-5,16-dioxo-2-(phenanthridin-6-yloxy)-1,2,3,6,7,8,9,10,11,13a,14,15,16,16atetradecahydrocyclopropa(E)pyrrolo(1,2-a)(1,4)diazacyclopentadecine-14a(5H)-carboxamideDTXSID601027922VIEKIRAX COMPONENT PARITAPREVIR(1S,4R,6S,7Z,14S,18R)-N-cyclopropylsulfonyl-14-[(5-methylpyrazine-2-carbonyl)amino]-2,15-dioxo-18-phenanthridin-6-yloxy-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamideCHEBI:85188emptyparitaprevirum
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Paritaprevir
Loading drug network...